烟酸缓释剂（ER）/辛伐他汀（Simcor®）：在血脂调节中的应用指南。
Niacin extended release (ER)/simvastatin (Simcor®): a guide to its use in lipid regulation.
机构信息
Adis, a Wolters Kluwer Business, Auckland, New Zealand.
出版信息
Drugs R D. 2010;10(4):253-60. doi: 10.2165/11202560-000000000-00000.
Abstract
Oral fixed-dose niacin extended release/simvastatin is associated with clinically relevant improvements in plasma lipid profiles, including lowering of non-high-density lipoprotein cholesterol levels, relative to simvastatin monotherapy in patients with mixed dyslipidemias who had not responded fully to simvastatin monotherapy, and is generally well tolerated.
摘要
口服固定剂量烟酸缓释/辛伐他汀与辛伐他汀单药治疗相比，可使混合性血脂异常患者的血脂谱得到临床相关改善，包括降低非高密度脂蛋白胆固醇水平，这些患者对辛伐他汀单药治疗反应不完全，且通常具有良好的耐受性。
Zotero 插件